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Abstract: Intracranial aneurysm (IA) rupture is one of the leading causes of stroke in the United 
States and remains a major health concern today. Most aneurysms are asymptomatic with a 
minor percentage of rupture annually. Regardless, IA rupture has a devastatingly high mortality 
rate and does not have speciﬁ  c drugs that stabilize or prevent aneurysm rupture, though other 
preventive therapeutic options such as clipping and coiling of incidental aneurysms are available 
to clinicians. The lack of speciﬁ  c drugs to limit aneurysm growth and rupture is, in part, attrib-
uted to the limited knowledge on the biology of IA growth and rupture. Though inﬂ  ammatory 
macrophages and lymphocytes inﬁ  ltrate the aneurysm wall, a link between their presence and 
aneurysm growth with subsequent rupture is not completely understood. Given our published 
results that demonstrate that the pro-inﬂ  ammatory cytokine, tumor necrosis factor-alpha (TNF-α), 
is highly expressed in human ruptured aneurysms, we hypothesize that pro-inﬂ  ammatory cell 
types are the prime source of TNF-α that initiate damage to endothelium, smooth muscle cells 
(SMC) and internal elastic lamina (IEL). To gain insights into TNF-α expression in the aneu-
rysm wall, we have examined the potential regulators of TNF-α and report that higher TNF-α 
expression correlates with increased expression of intracellular calcium release channels that 
regulate intracellular calcium (Ca2+)i and Toll like receptors (TLR) that mediate innate immu-
nity. Moreover, the reduction of tissue inhibitor of metalloproteinase-1 (TIMP-1) expression 
provides insights on why higher matrix metalloproteinase (MMP) activity is noted in ruptured 
IA. Because TNF-α is known to amplify several signaling pathways leading to inﬂ  ammation, 
apoptosis and tissue degradation, we will review the potential role of TNF-α in IA formation, 
growth and rupture. Neutralizing TNF-α action in the aneurysm wall may have a beneﬁ  cial 
effect in preventing aneurysm growth by reducing inﬂ  ammation and arterial remodeling.
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Introduction
Intracranial aneurysm (IA) is prevalent among both elderly men and women. In the 
United States, unruptured IA is present in approximately 4%–5% of the general 
population. Many IA are clinically silent until they rupture with devastating clinical 
consequences. Although only 1%–2% of IA ruptures annually, the neurological dam-
age associated with rupture is often irreversible (Juvela et al 2000; Peters et al 2001; 
Ruigrok et al 2005; Nahed et al 2007). Approximately 1/3 of ruptured IA is fatal, with 
1/3 of patients suffering notable neurological damage, and the remaining 1/3 of patients 
are neurologically normal following subarachnoid hemorrhage (SAH). Despite their 
clinical importance, the pathogenesis of IA remains obscure.
Although the exact etiology of IA disease is not known, there are many risk factors 
that are associated with the weakening of cerebral arteries (Ostergaard 1989; Juvela 2002; 
Hashimoto et al 2006). They include hypertension, hemodynamic stress, atherosclerosis, 
smoking, aging, and genetic abnormalities such as Marfan syndrome, pseudoxanthoma 
elasticum, Ehlers-Danlos syndrome, ﬁ  bromuscular dysplasia, and polycystic kidney disease. Vascular Health and Risk Management 2008:4(4) 806
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Therefore, it was suggested that aneurysms, namely berry type, 
infectious, dissecting, and giant partially thrombosed, are dif-
ferent with respect to their behavior, topography, localization, 
and association with certain genetic or familial diseases and 
represent a wide variety of diseases triggered by hemodynamic 
and nonhemodynamic factors. The berry type is not regarded 
as the same disease as the giant chronic dissecting aneurysms 
because the latter demonstrate a multifocal character suggesting 
nonhemodynamic triggering factors. In addition, giant aneurysms 
behave differently over time, with about 50% thrombosing, 
whereas only 2% of berry aneurysms show complete thrombosis. 
In this study, Zhao and his colleagues (2004) have noted 
that the weakening of aneurysmal artery does not occur from 
the inside of the vessel, rather it is caused from the outside by 
abluminal factors via leukotrienes (LT) release by 5-LO pathway 
that initiates adventitial inﬂ  ammation by weakening the media 
and dilating the vessel conducive for aneurysm formation.
While this and other studies reinforce that inﬂ  ammation 
plays a role in aneurysm pathogenesis, a common pathogenic 
mechanism associated with these risk factors has not yet 
been identiﬁ  ed. Given several risk factors are associated 
with aneurysm growth, it is not unreasonable to expect the 
involvement of multiple signaling molecules or pathways. 
Recently, we have reported that the pro-inﬂ  ammatory 
cytokine, tumor necrosis factor-alpha (TNF-α), is highly 
expressed in cerebral aneurysm walls (Jayaraman et al 
2005) and propose that its expression and activation by 
these risk factors can be linked to the onset of IA through a 
remarkable series of correlations. In this review, we provide 
an overview of its potential role in aneurysm formation 
with molecular insights gained from tumor necrosis factor 
receptor (TNFR) signaling and TNF-α-dependent cellular 
mechanisms.
Evidence for the presence 
of inﬂ  ammation in cerebral 
aneurysms
Inﬂ  ammation is a vital process that plays a key role in health 
and disease (Henry and Chen 1993; Slifka and Whitton 
2000; Hotamisligil 2006). It is initiated by a complex series 
of events that lead to changes in vascular wall integrity, and 
emerges as a shared pathological mechanism in a variety 
of vascular diseases, including atherosclerosis, abdominal 
aortic aneurysm, and arteritis (Henry and Chen 1993; Jang 
et al 1993). Although inﬂ  ammation has been suggested to 
be an underlying cause of cerebral aneurysms (Chyatte et al 
1999), it was largely ignored until recent ﬁ  ndings demon-
strated the presence of inﬂ  ammatory cells (macrophages, 
T- and B-lymphocytes) in the walls of human IA (Chyatte 
et al 1999; Kataoka et al 1999) with increased levels of 
matrix metalloproteinases and other proteolytic enzymes 
in the serum of aneurysm patients (Toder et al 1998) and 
polymorphisms (Zhang et al 2001; Krex et al 2003). Comple-
ment, an important part of the innate and adaptive immune 
system, was found in almost all aneurysms studied. Both 
C3, the most abundant complement protein in the blood, 
and C9, the terminal protein of the complement cascade, 
were found within cerebral aneurysms, and together act as 
a marker for complement activation (Chyatte et al 1999). 
The fact that half of all unruptured aneurysms (10/20) and 
all of the ruptured aneurysms (40/40) are inﬁ  ltrated with 
inﬂ  ammatory leukocytes suggests that inﬂ  ammatory cells and 
their mediators contribute to aneurysm growth and rupture 
(Kataoka et al 1999). However, it is not known if different 
subsets of inﬂ  ammatory leukocytes dominate in ruptured as 
compared with nonruptured aneurysms.
Pro-inﬂ  ammatory protein 
mediators
Inﬂ  ammation in the aneurysm wall is likely to be controlled by 
the relative balance of pro- and anti-inﬂ  ammatory cytokines 
(Slifka and Whitton 2000; Benelli et al 2006). Some of the 
prominent pro-inﬂ  ammatory cytokines include interleukin 
1β (IL-1β), IL-6, IL-8, IL-18, interferon-gamma (IFN-γ), 
and TNF-α, predominantly secreted by macrophages and to 
a lesser extent by lymphocytes (Xing et al 1998; Aggarwal 
and Takada 2005). These cytokines may increase systemic 
inﬂ  ammatory processes by upregulating acute phase protein 
synthesis and promoting permeability across blood–brain 
barrier (BBB) into the aneurysm wall.
Several groups have analyzed cytokine mRNA and protein 
expression in IA and it is now apparent that many cytokines 
are expressed abundant in IA including IL-1β, IL-6, TNF-
α, and chemokines, IL-8, and monocyte chemo-attractant 
protein-1 (MCP-1) (Cao et al 2002; Jayaraman et al 2005; 
Morgan et al 2006; Moriwaki et al 2006). While these studies 
indicate that cytokine expression in IA walls may be pro-
longed, it is not known whether they are a cause or an effect 
of aneurysm formation. Moreover, a plethora of cytokines 
detected in IA would suggest the existence of a hierarchy in 
terms of importance in the pathogenesis of IA. TNF-α’s ability 
to regulate other pro-inﬂ  ammatory cytokines is demonstrated 
by TNF-α neutralization studies in rheumatoid arthritis (RA) 
with markedly reduced production of IL-1, IL-6, and IL-8 
(Maini et al 1995). These results imply that in inﬂ  amma-
tory disease states, pro-inﬂ  ammatory cytokines are linked Vascular Health and Risk Management 2008:4(4) 807
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in a sequence resembling an electrical circuit in series, with 
TNF-α at the apex of the cascade in IA inducing production 
of IL-1, and both TNF-α and IL-1 inducing downstream 
cytokines such as IL-6 and IL-8. The lack of IL-10 in human 
ruptured aneurysms suggests that anti-inﬂ  ammatory cytokines 
are not either activated or suppressed in the aneurysm wall. 
Absence of IL-10 generation could be due to either T helper2 
(Th2) cells being absent or suppressed. Our data points to the 
latter, as our unpublished results show that Th2 cell types 
are present. In addition to pro-inﬂ  ammatory cytokines, other 
mediators may also be involved. However, it is not known if 
their activation is the cause or effect of inﬂ  ammation mediated 
by pro-inﬂ  ammatory cytokines (Morgan et al 2005).
Pro-inﬂ  ammatory lipid mediators
In addition to protein pro-inﬂ  ammatory mediators such as 
TNF-α, lipid mediators can also cause inﬂ  ammation in vascu-
lar walls. 5-lipooxygenase (5-LO) has recently attracted atten-
tion because of their involvement in synthesis of leukotriene 
(LT), a group of pro-inﬂ  ammatory lipid mediators derived 
from arachidonic acid. Both experimental and clinical studies 
implicate 5-LO pathway in the pathophysiology of asthma 
and atherosclerosis. The expressions of 5-LO in mammals are 
tightly regulated and are modulated in vitro by calcium (Ca2+), 
adenosine triphosphate (ATP), phosphatidylcholine, and lipid 
hydroperoxides. Ca2+ ions (0.5 μM concentrations or higher), 
but not Mg2+ or Mn2+, activate 5-LO by dimerizing the inactive 
5-LO into an active form (180 KD) (Parker and Aykent 1982). 
Interestingly, LO-5 pathway is also known to induce pro-
inﬂ  ammatory cytokines, including TNF-α generation, via LT 
production. For instance, LTB4 of synovial membrane cells 
in rheumatoid arthritis induce TNF-α and IL-1β expression at 
mRNA level (Chen and Lv 2006) and 5-LO inhibitors, VZ-65 
and AA-861, signiﬁ  cantly inhibit TNF-α production, whether 
administered simultaneously with lipopolysaccharide (LPS) 
or 30 min after LPS treatment. While these studies suggest 
that 5-LO can induce TNF-α expression, whether TNF-α, as a 
downstream signal, could also be involved in giant aneurysms 
pathogenesis is yet to be determined.
Though we have not determined 5-LO in our study, 
increased IP3R expression suggests that several Ca2+-
dependent pro-signaling molecules, including 5-LO, might 
be activated in aneurysm wall. Our ﬁ  ndings thus provide a 
novel mechanism by which different signaling pathways are 
activated in aneurysm wall and a new strategy for preventing 
IA growth and rupture.
TNF-α links risk factors 
with aneurysm development
Multiple systemic risk factors, including hypertension, 
hemodynamic stress, age (50 years), atherosclerosis, smok-
ing, alcohol consumption, and gender differences (females 
have higher cerebral aneurysm rate as compared with men 
with ~1.6 to 1 ratio), are involved in the pathogenesis of IA. 
However, it has not been possible to associate these risk 
factors with a common pathogenic mechanism. We have 
shown that TNF-α is signiﬁ  cantly expressed in ruptured 
cerebral aneurysm walls, whose expression/activity can also 
be linked with cerebral aneurysms growth. These include 
observations that 1) TNF-α generation occurs in response 
to each of these diverse risk factors associated with cerebral 
aneurysm growth (Table 1); 2) atherosclerotic lesions form 
Table 1 Tumor necrosis factor-alpha (TNF-α) generation is a common signal associated with intracranial aneurysm risk factors. The studies 
show that TNF-α induction is associated with each of the known aneurysm risk factors
Risk factors TNF-α induction References
Hemodynamic ﬂ  ow Yes Gonzalez et al 1992; Kapadia et al 2000; Hoi et al 
2004; Jou et al 2005
Hypertension Yes Munoz et al 1999
Aging Yes, intracellular expression of TNF-α 
increases progressively with age
Paolisso et al 1998; Kirwan et al 2001; Hartel 
et al 2005
Gender Yes, estrogen inhibits TNF-α activity Puder et al 2001; Schrman et al 2001; Huang et al 
2005; Ferreri 2007
Smoking Yes, smoking increases residual TNF-α
activity in vessels
Anto et al 2002; Sun et al 2007; Wright et al 2007
Alcohol Yes Gonazalez-QA 2004;  Luedemann et al 2005; 
Lanzke et al 2007
Genetic Yes Zhai et al 1997; Gregersen et al 2000; Ruetzler 
et al 2001; Lambertsen et al 2002
Abbreviation: TNF-α, tumor necrosis factor-alpha.Vascular Health and Risk Management 2008:4(4) 808
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at distinct regions of the arterial tree, especially at or near 
branch points or major vascular curvatures where TNF-α is 
selectively expressed; and 3) inﬂ  ammatory macrophages and 
lymphocytes are present in the aneurysm wall (Chyatte et al 
1999). Although these correlations are provocative, there is 
no direct evidence demonstrating that TNF-α activation is 
necessary or sufﬁ  cient for aneurysm formation. Given TNF-α 
alters BBB functions permitting inﬂ  ammatory cells across 
the BBB to the vascular injury site, we propose that TNF-α 
generation by these risk factors is an important early signal 
that initiates the groundwork for cerebral aneurysm develop-
ment and growth via its signaling activation.
In addition to activating speciﬁ  c signaling events, TNF-α 
can also have indirect effects on the aneurysm wall through 
activation of other signaling molecules such as tissue factor 
(TF), adhesion molecules for leukocytes, release of IL-1, 
nitric oxide, factor VIII/von Willebrand factor, platelet acti-
vating factor, endothelin, which will have profound effect 
on the arterial wall (Tracy et al 1993). The effect of TNF-α 
on intracranial vessel has been studied in stroke models. 
For instance, intracranial blood vessel activation by either 
intracisternally administered LPS or chronic activation of 
BCG-primed monocytes/macrophages renders rats sensitive 
to hemorrhage (Sirén et al 2001). The fact that administration 
of a recombinant type 1 soluble TNF receptor (TNF binding 
protein) prevents these strokes suggests TNF-α as a necessary 
casual factor. Moreover, the gene expression pattern by TNF-α 
and LPS appears to be very similar (Magder et al 2006). 
The role of TNF-α in stroke has been studied in mice that 
lack TNF receptor 1 (TNFR1) and TNFR2. The accelerated 
plaque development in TNFR1-deﬁ  cient mice suggests that 
some level of TNFR1 signaling is necessary to protect the 
arterial wall from atherosclerosis. One must reconcile these 
contradictory signals that TNF-α may be necessary for both 
protection and aneurysm growth. Characterization of TNFR-
mediated signaling events during aneurysm progression in 
mice may lead to a better understanding of aneurysm forma-
tion, growth, and rupture.
Hemodynamics
The fact that majority of aneurysms occur at arterial bifurca-
tions suggest that hemodynamic stress is a signiﬁ  cant factor 
in IA formation and growth (Gonzalez et al 1992; Hoi et al 
2004; Jou et al 2005). Disturbed ﬂ  ow has been a key concept 
in the onset of thrombosis and inﬂ  ammation, in part due to 
recirculating ﬂ  ow in a cavity or at an arterial branch. Blood 
elements stay in the region for a prolonged period, greatly 
increasing the adhesion of elements such as platelets and 
monocytes to endothelial cells (EC). While increasing evi-
dence suggests that high wall stress triggers TNF-α gene 
expression in ECs that leads to inﬂ  ammation-mediated dys-
function including expression of MMP in vessel that may 
degrade the vessel wall, as circulating levels of TNF-α are 
increased in patients with hemodynamic pressure and volume 
overload (Kapadia et al 2000).
Hypertension
Although systemic hypertension is a known risk factor in 
aneurysm development, it is not understood how systemic 
hypertension contributes to aneurysm development. It is 
likely that intravascular pressure subjects the vessel wall 
to tensile stress, which could cause the aneurysmal sac to 
enlarge if the focal site of hemodynamic ﬂ  ow is damaged 
(Kapadia et al 2000). However, this simple view does not 
uniquely explain how systemic hypertension contributes 
to the vessel wall degradation that is essential to aneu-
rysm development and growth. We propose that systemic 
hypertension increases EC calcium and TNF-α, which do 
the initial damage by necrosis of EC providing an opening 
for vessel out-bulging (Munoz et al 1999). As a result, the 
aneurysm wall is very nonhomogenous with a disrupted 
endothelial layer permitting inﬂ  ammatory macrophages 
into other compartments of the artery. While hypertension 
may contribute to the increased level of TNF-α, it appears 
that altered hemodynamic force is a necessary component to 
promote aneurysm growth as a ready source of inﬂ  ammatory 
cells to the vascular wall site.
Gender
Alterations in vascular function, including reduced 
bioavailability of nitric oxide and reduction in responses to 
shear stress with increased cardiovascular risk associated 
with aging appear related to the onset of menopause 
(Kongable et al 1996; Henneke and Goldenbock 2001). 
Female preponderance for SAH is unclear though it is known 
that estrogen has an inhibitory effect on aneurysm formation. 
Since estrogen is known to inhibit TNF-α activity (Srivastava 
et al 1999; Puder et al 2001; Xing et al 2007), we suggest 
that reduced estrogen levels in postmenopausal women 
predispose to a higher incidence of aneurysm development. 
The collagen content of cerebral arteries may also diminish 
after menopause, favoring aneurysm formation (Hoh et al 
2004). Estrogen attenuates vascular smooth muscle cell 
(VSMC) expression of adhesion molecules and chemo-
attractants, and protects against vascular inflammation 
(Ferreri 2007). The demonstration by Xing and colleagues Vascular Health and Risk Management 2008:4(4) 809
TNF-α and intracranial aneurysm growth
(2007) that estrogen can act as an antagonist of TNF-mediated 
pro-inﬂ  ammatory pathways via inhibition of (CINC-2β) is 
especially noteworthy in this regard (Hoh et al 2004). In 
agreement with our hypothesis, increased circulating levels 
of TNF-α have been observed in postmenopausal women 
(Huang et al 2005; Xing et al 2007). By altering BBB, 
TNF-α can sustain inﬂ  ammation by permitting inﬂ  ammatory 
molecules (Schurman et al 2001; Ferreri 2007).
Smoke
Cigarette smoking has been shown, in several studies, to 
increase the risk for SAH in all age groups (Longstreth et al 
1992; Juvela et al 1993; Weir et al 1998), but the mechanism 
remains unknown. According to these ﬁ  ndings, it appears 
that smoking increases risk for SAH by hastening growth 
of pre-existing aneurysms. Interestingly, the number of 
cigarettes smoked daily appears to be more important than 
the duration of smoking, which suggests that the inﬂ  ammation 
threshold is significantly increased with the number of 
cigarettes. It is also interesting to note that cigarette smoking 
has antiestrogenic properties, indirectly upregulating TNF-α 
signaling as demonstrated in the pulmonary vessels (Wright 
et al 2007). While cigeratte smoke can cause many systemic 
effects (Yanbaeva et al 2007), cigarette smoke could also 
increase structural fragility by decreasing collagen production 
(Raveedran et al 2004; Wright et al 2007) and increasing 
nuclear factor-kappa-B (NFκB) activation (Anto et al 2002).
TNF-α:   A key player in inﬂ  ammation, 
apoptosis, and arterial degradation
TNF-α acts via two distinct receptors (Grell et al 1994; 
Bazzoni and Beutler 1996). TNFR1 is constitutively 
expressed in most tissues, binds primarily to the soluble 
form of TNF-α and is the key mediator of TNF-α signaling 
in many cell types. On the other hand, TNFR2 is typically 
expressed in endothelial and immune-related cells and is 
activated by the membrane bound TNF-α. Since the afﬁ  nity 
of TNF receptor 2 (TNFR2) is ﬁ  ve times higher than that 
for TNFR1 (Pimentel-Muinos and Seed 1999), one domi-
nant effect would be to activate TNF signaling on ECs via 
NFkB (Figure 1). However, the latter initiates the majority 
of the biological activities of TNF-α. The major difference 
between the two receptors is the death domain (DD) of 
TNFR1 that is absent in TNFR2. For this reason, TNFR1 
is an important member of the death receptor family that 
activates both cell death and survival signals (Grell et al 
1994; Bazzoni and Beutler 1996; Tang et al 1998; Pimentel-
Muinos and Seed 1999).
The TNF-α signaling via TNFR1 and TNFR2 are depicted 
in Figure 1 (Grell et al 1994). The TNFR-associated death 
domain (TRADD) binds to the DD of TNFR1 and recruits 
the adapter proteins receptor interacting protein (RIP), 
TNFR-associated factor 2 (TRAF-2), and Fas-associated 
death domain (FADD). In turn, these adaptor proteins 
recruit key molecules that are responsible for further intra-
cellular signaling. When TNFR1 signals apoptosis, FADD 
binds pro-caspase 8, which is subsequently activated. This 
activation initiates a protease cascade leading to apoptosis, 
also involving the mitochondria and with caspases as key 
regulators (Tantral et al 2004). Alternatively, when TNFR1-
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Figure 1 Proposed TNF-α signaling during aneurysm growth and rupture. TNF-α 
interaction with TNFR1 and TNFR2 elicits either inﬂ  ammation/survival or apoptosis 
by recruiting different adaptor proteins. Recruitment of FADD and TRADD leads to 
activation of apoptosis while recruitment of RIP and TRAF2 generates NFκB, initiating 
inﬂ  ammation. During early stages of aneurysm development, membrane bound TNF 
interacts with TNFR2 and initiates EC activation. The threshold of membrane bound 
TNF-α appears to control EC activation and survival. While lower TNF-α expression 
would be expected to activate EC, higher TNF-α concentration would cause EC dys-
function and a fraction of EC death. However, the majority of EC/SMC apoptosis would 
occur when soluble TNF-α interacts with TNFR1 (present on EC and SMC) (Norwak 
et al 2000). The threshold of soluble TNF-α is critical, as lower concentration would 
increase SMC proliferation, which might stabilize aneurysms from rupturing (stable 
aneurysms) (Fig. 4). On the other hand, sustained TNF-α might activate MMPs and 
other calcium dependent proteases such as calpain promoting aneurysm rupture.
Abbreviations: TNFR, Tumor necrosis factor receptor; FADD, Fas associated death 
domain; TRADD, TNF receptor associated death domain Receptor; EC, Endothelial 
cells; SMC, Smooth muscle cells; NFKB, Nuclear factor for kappa B; NIK, NFKB 
inducing kinase; IKK, Inhibitor of 1 kappaB kinase; JNK, c-Jun N-terminal kinase; 
Bid, BH3 interacting domain.Vascular Health and Risk Management 2008:4(4) 810
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signals survival, TRAF-2 is recruited to the complex, which 
inhibits apoptosis via cytoplasmic inhibitor of apoptosis 
protein (cIAP). The binding of TRAF-2 initiates a pathway of 
phosphorylation steps resulting in the activation of cFos/cJun 
transcription factors via mitogen activated protein kinase 
(MAPK) and cJun N-terminal kinase (cJun). The major 
signaling event of TRAF-2 and RIP is the widely studied 
activation of NFκB transcription factor (Pimentel-Muinos 
and Seed 1999). Both NFκB and cFos/Jun induce transcrip-
tion of antiapoptotic and pro-inﬂ  ammatory genes. Given 
the differential action of TNF-α receptors, we suggest that 
during early stages of aneurysm formation TNFR2 signaling 
is activated by membrane-bound TNF-α and when sufﬁ  cient 
TNF-α is secreted , it activates TNFR1-signaling resulting 
inﬂ  ammation and apoptosis.
TNF-α is known to activate metalloproteinases (MMPs) 
that increase vascular permeability and hemorrhage 
(Polavarapu et al 2005). MMPs consist of at least 
18 different mammalian zinc- and calcium-dependent 
proteases, of which monocytes/macrophages express 
several types. Most MMPs are synthesized in their latent 
pro-form and converted to their active forms. MMPs have 
broad substrate speciﬁ  city in degrading most extracellular 
proteins and play important roles in normal and pathological 
conditions. MMP activities are tightly regulated by 
endogenous inhibitors, (TIMPS), and degrade the principal 
structural components, collagen and elastin in the artery 
(Van den Berg et al 1999; Yoneyama et al 2004). Our 
results indicate reduction in TIMP-1 expression in human 
ruptured aneurysms with concurrent increase in MMP-9 
activity. It is assumed that initiation, growth and rupture 
are begun from the localized degeneration of the internal 
elastic membrane at the apices of intracranial arterial 
bifurcations. This degeneration by the hemodynamically 
generated forces acts at the apex and weaken the wall 
(Gonzalez et al 1992). The pulsatile impulse and pressure 
produces the initial aneurysmal out-pouching. Growth, or 
enlargement, occurs as a process of structural fatigue due 
to inﬁ  ltration of inﬂ  ammatory cell types and their mediators 
progressively weaken the structural components of the wall. 
The architecture of the normal cerebral artery (Figure 2A) 
with degenerating aneurysm wall is shown to indicate the 
differences in TNFα signaling (Figure 2B). We propose that 
aneurysm rupture occurs when the combination of intra-
aneurysmal pressure, aneurysmal size, and thinning of the 
aneurysm wall with sustained activation of inﬂ  ammation 
by TNF-α exceeds the breaking strength of the structural 
components of the wall (Figure 2C). We suggest that 
downregulating TNF-α-mediated inﬂ  ammation (inactive 
inﬂ  ammatory cell types) would prevent aneurysm growth 
and rupture by blocking activation of MMPs (Figure 2D).
TNF-α initiates aneurysm 
formation through EC dysfunctions
Though a relatively small organ, the brain is an intricate part 
of the body that demands and uses 20% of the volume of 
blood pumped from the heart. The blood vessels can handle 
an increased or decreased volume of blood into the brain with 
an intricate multilayer system of different cell types that work 
together to support sufﬁ  cient hemodynamic ﬂ  ow (Ruetzler 
et al 2001). In normal arteries, the vascular endothelium 
serves as a natural barrier between the blood and other vas-
cular cell types preventing damage. ECs play a pivotal role in 
inﬂ  ammation, in that they constitute the “survey strategy” of 
the innate immune system to thwart most pathogenic threats. 
EC activation initiates the inﬂ  ammatory response by recruit-
ing leukocytes into the damaged arterial site(s); therefore 
EC dysfunction contributes to the development of a chronic 
inﬂ  ammatory response. Leukocyte-endothelial interactions 
can be divided into three main steps: rolling, ﬁ  rm adhesion, 
and emigration (Vestweber 2007). The initial tentative 
contact between circulating white blood cells and the vessel 
wall, known as rolling, is mediated by the binding of selectin 
molecules on the endothelium (E-selectin and P-selectin) 
or leukocytes (L-selectin) to their corresponding ligands. 
This slows the leukocytes down, essentially increasing the 
likelihood that they will ﬁ  rmly adhere to the vessel wall via 
other cell adhesion molecules (CAM), such as intercellular 
adhesion molecule-1 (ICAM-1) and vascular cell adhesion 
molecule-1 (VCAM-1) on the vascular endothelium, and 
integrins such as CD11/18 on the leukocytes. These two 
families of CAMs are also responsible for the subsequent 
transmigration of the leukocytes through the vessel wall into 
the interstitium where they can promote further tissue damage 
(Figure 2). TNF-α is a potent pro-inﬂ  ammatory cytokine that 
triggers strong endothelial activation with increased mono-
cyte adhesion, the hallmark of the inﬂ  ammatory response. 
Characterization of TNF-mediated signaling events that 
cause tissue damage can be therapeutically manipulated using 
speciﬁ  c antibodies or inhibitors.
While vascular endothelium maintains the integrity of a ves-
sel, vascular smooth muscle cells (VSMC) that are positioned 
below endothelium play a crucial role in the malleability of the 
arterial wall. SMC, in concert with the ﬁ  brous layers of colla-
gen and elastin, give arteries the plasticity needed to withstand 
hemodynamic stress without sustaining any signiﬁ  cant injury. Vascular Health and Risk Management 2008:4(4) 811
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However, this structural integrity is lost in IA and more so in 
ruptured aneurysms supported by the ﬁ  ndings that ruptured 
aneurysms are more pulsatile than nonruptured aneurysms.
Potential cellular mechanisms 
that sustain TNF-α expression 
during IA growth
Increased Ca2+-signaling
Though TNF-α expression is regulated in cells by several 
factors including nuclear factor for activated T (NFAT) 
activation (an intracellular Ca2+-sensitive transcription 
factor) and TNF-α converting enzyme (TACE) activity. 
Studies from several laboratories, including ours, indicate 
that NFAT activation requires IP3-gated Ca2+-release and 
Ca2+-inﬂ  ux across the plasma membrane (Jayaraman et al 
2000). To determine whether higher TNF-α activity could be 
due to increased intracellular Ca2+, we performed polymerase 
chain reaction (PCR) analysis using speciﬁ  c primers for 
Inositol 1,4,5-trisphosphate receptor 1 (IP3R1) and IP3R3, 
predominantly expressed intracellular Ca release channels in 
inﬂ  ammatory and endothelial cells. Representative data in the 
aneurysm wall is shown in Figure 3A, which indicates higher 
IP3R1 and IP3R3 expression in human ruptured aneurysm 
wall as compared to control artery (Fig. 3B). The implica-
tion of these results could be that up-regulated IP3Rs may 
increase focal Ca2+ concentration, sustaining Ca2+-dependent 
signaling molecules activation including TNF-α in human 
aneurysms.
Toll-like receptors in aneurysm wall
In response to pathogen invasion, the immune system relies 
on pathogen sensors before mounting an effective immune 
response to the pathogen (Aderem and Ulevitch 2000). 
These pathogen sensors are Toll-like receptors (TLR), which 
directly bind to the pathogenic ligand leading to an immune 
response. Most TLR ligands are microbial products that 
are conserved among a variety of pathogens. TLRs have 
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Figure 2 Potential role of TNF-α-mediated inﬂ  ammation in aneurysm progression and rupture. A. Architecture of a normal cerebral artery is shown with endothelial cells at 
the lumen followed by internal elastic lamina, smooth muscle cells in media, and adventitia. B. Aneurysm wall is characterized by the inﬁ  ltration of inﬂ  ammatory cell types that 
lead to loss of endothelial cells, degeneration of internal elastic lamina and smooth muscle cells. C. Presence of active inﬂ  ammatory cells (as shown in red) that produce TNF-α 
is an indicative of aneurysm rupture. D. Inactive inﬂ  ammatory cells (as shown in green) as a result of either suppressed TNF-α expression or increased anti-inﬂ  ammatory 
cytokines are indicative of aneurysm stabilization (nonrupture).
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been grouped into families depending on the recognition 
of ligands (Takeda et al 2003). Lipid-based structures are 
recognized by TLR2 and bacterial LPS is recognized by 
TLR4. Viral and bacterial nucleic acids are recognized by 
TLR3, TLR7, TLR8, and TLR9. Double-stranded RNA 
(dsRNA) is recognized by TLR3. TLR5 recognizes proteins 
from pathogens. TLRs seem to require co-receptors for 
microbial recognition and signaling. For instance CD14, 
which is present in plasma as a soluble form or on the 
monocyte cell surface as a glycosylphosphatidylinositol 
(GPI)-anchored 50 KD protein, binds to LPS and facilitates 
its signaling. Mice lacking CD14 reveal that CD14 has a 
role in amplifying the production of TNF-α and IL-6 during 
LPS responses (Takada and Aggarwal 2003). Another co-
receptor, CD36, mediates homeostatic functions, including 
adhesion to thrombospondin and collagen and the inhibition 
of angiogenesis. CD36 acts as a co-receptor for diacyl 
glyceride (DAG) recognition through the TLR2/6 complex. 
The fact that expression of several TLRs is increased in our 
study indicates that bacterial and viral infections in a given 
individual might leave a component that is recognized by 
TLR-6 and TLR-2 (Figure 3) (Paul-Clark et al 2006). Given 
that Gram-positive agonists induce TNF-α in macrophages, 
it is interesting that Staphylococcus aureus has been noted in 
bacterial intra-cerebral aneurysms (Byrd-Leiffer et al 2001) 
and in infected IA (Whitﬁ  eld et al 1991). We propose that 
TNF generation and activation by the innate immune system 
is an important component of the inﬂ  ammatory response in 
cerebral arteries because of its ability to alter blood ﬂ  ow and 
vascular permeability permitting accumulation of immune 
Figure 3 Activation of TNF-α regulatory molecules in human ruptured aneurysms. Representative PCR analysis of IP3R1, IP3R3 (A) and TLRs (C) and TIMP-1 (E) using 
speciﬁ  c oligonucleotide primers. B. Quantitation of IP3R1 and IP3R3 (B), TLRs (D), TIMP-1 (F) using NIH image software. In all these assays, internal control has been used 
to normalize quantitation. The lower IP3R1 and IP3R3 expression in control artery is not due to insufﬁ  cient DNA template, as β-actin expression (a housekeeping gene) was 
slightly higher in controls than in aneurysm samples (A).
Abbreviations: PCR, Polymerase chain reaction; IP3RI, Inositol 1, 4,5-trisphosphate receptor 1; TLR, Toll like receptor; TIMP-1, Tissue inhibitor of metalloproteinase-1; GAPDH, 
Glyceraldehyde-3P-dehydroganase.
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cells in the brain (Karikó et al 2004). Since TLR-2 and 
TLR-6-mediated TNF-α and IL-6 generation is accompanied 
by the classical signs of brain-controlled illness responses in 
rats, it is reasonable to suggest that increased TNF-α expres-
sion by these TLRs in aneurysm wall might contribute to 
the neurological damage (Figure 3C and D) (Hübschle et al 
2006). The TLR-2 signaling (as well as TLR-6) is medi-
ated via activation of the myeloid differentiation factor 88 
(MyD88) and Myd88 adapter-like (Mal) protein pathways. 
Detailed analysis of TLRs in nonruptured and ruptured 
aneurysms would provide a clue on their role in the patho-
physiology of aneurysm development.
TIMP1 expression is reduced 
in aneurysm wall
Extracellular matrix remodeling is associated with and may 
play a role in the formation and rupture of aneurysms. The 
aneurysms develop when structural proteins are broken 
down which allows the arterial wall to bulge out. MMPs are 
believed to be responsible for damaging the structural pro-
teins and thus contributing to the growth of the aneurysms. 
The regulator of MMP is a group of TIMP that suppress 
their activity in normal vessels and their reduction would 
allow higher MMP activity promoting aneurysm formation. 
To determine if TIMP expression is reduced in aneurysm 
walls, we performed PCR analysis using speciﬁ  c primers. 
Our results show that TIMP-1 expression is signiﬁ  cantly 
reduced in aneurysm walls (Figure 3E and F). Though we 
have reported that that IP3R, TLR, and TIMP-1 expressions 
are increased/altered in aneurysm wall, we do not know the 
induction of these genes is the cause or consequence of these 
aneurysms growth.
TNF-α threshold is critical 
for maintaining normal vessel integrity
Since TNF-α has both protective and detrimental effects on 
cells under certain conditions, we hypothesize that threshold 
of TNF-α activity is important in the pathogenesis of cere-
bral aneurysms growth and rupture (Figure 4). We suggest 
that during early stages of aneurysm cerebral aneurysm 
formation, TNF-α expressed is mostly membrane bound 
on luminal EC, which lead to endothelial activation. How-
ever, when EC’s express both membrane bound and secrete 
TNF-α‚ EC dysfunctions and apoptosis occur. Apoptosis 
of few ECs provides opening for aneurysm formation and 
for inﬂ  ammatory cells to inﬁ  ltrate into inner layers of the 
vessel to promote aneurysm growth and is facilitated by the 
hemodynamic ﬂ  ow. TNF-α secretion from inﬂ  ammatory 
cells would increase smooth muscle cell (SMC) growth 
initially (Wang et al 2005), followed by apoptosis when 
the number of macrophages are increased at the site, which 
lead to MMP generation that induce structural breakdown. 
We, therefore, consider TNF-α is a critical signaling mol-
ecule involved in berry-type aneurysm pathogenesis. When 
inﬂ  ammatory cells are inactivated or reduced below threshold 
by either anti-inﬂ  ammatory cytokines or other modulators, 
SMCs will provide stability to the vessel preventing rupture 
(nonrupture).
TNF-α polymorphisms in IA
Fontanella and colleagues (2007) have shown recently that 
the G allele, associated with less TNF-α transcription, is more 
frequent in SAH and suggest that TNF-α protects aneurysm 
from rupture. The TNF-α–308G/A polymorphism has been 
extensively studied in the context of numerous inﬂ  ammatory 
Figure 4 Threshold of TNFα expression is critical for aneurysm growth. TNF-α is a known inducer of inﬂ  ammation and the extent TNF-α expression correlates the degree 
of inﬂ  ammation, which determines aneurysm growth and rupture. SP refers to structural proteins.
Abbreviations: EC, endothelial cell; SMC, smooth muscle cell; SP, structural proteins; TNF-α, tumor necrosis factor-alpha.
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disorders. Since inﬂ  ammatory cell types and reactions are 
well established in ruptured aneurysms, the differences 
between our studies cannot be explained. As authors them-
selves pointed out in this study, additional genetic studies are 
required in different populations to validate their interesting 
ﬁ  ndings. However, there are several possible explanations. 
First, it is known that the allele frequencies of single nucleo-
tide polymorphisms (SNPs) differ greatly among different 
populations/races. Second, while TNF-α2 allele with “A” is 
a stronger transcriptional activator than the TNF-α1 allele 
containing “G” (Wilson et al 1992; Hajeer and Hutchinson 
2001), there are other SNPs (–238, –1031, –863, and –857) 
that regulate TNF-α as well. For example, TNF-α SNPs, 
–1031, –863, and –857, variants of which are observed in a 
relatively large proportion of Japanese, have been suggested 
to relate to high TNF-α production. In addition, the level of 
TNF-α production from conconavalin A (ConA) -activated 
peripheral blood mononuclear cells carrying either –857T or 
–863A (variant alleles) was signiﬁ  cantly higher than those 
carrying –857C and –863C (dominant alleles) (Higuchi et al 
1998). Alternatively, additional gene(s), in addition to TNF-α, 
may participate in tandem to inﬂ  uence the individual’s 
susceptibility or severity and may vary in different popula-
tions. For example, HLA-DR gene’s proximity to TNF-α 
suggests this possibility (Wilson et al 1993).
Since TNF-α has both protective and detrimental 
effects on cells under certain conditions, we hypothesize 
that threshold of TNF-α activity may be important in the 
pathogenesis of cerebral aneurysms growth and rupture 
(Figure 4). We suggest that, during early stages of aneurysm 
cerebral aneurysm formation, TNF-α expressed on luminal 
EC is mostly membrane-bound, which lead to endothelial 
activation. However, when EC’s express higher levels of 
TNF-α, membrane-bound and secreted forms, which lead 
to EC dysfunctions and apoptosis, respectively. Apoptosis 
of few ECs provides opening for aneurysm formation and 
for inﬂ  ammatory cells to inﬁ  ltrate into inner layers of the 
vessel to promote aneurysm growth and is facilitated by the 
hemodynamic ﬂ  ow. TNF-α secretion from inﬂ  ammatory 
cells would increase SMC numbers initially, followed by 
apoptosis when the number of macrophages are increased at 
the site, which lead to MMP generation and structural break-
down. We, therefore, consider TNF-α is a critical signaling 
molecule involved in berry-type aneurysm pathogenesis. 
When TNF-α concentration is reduced below threshold by 
inactivating or reducing inﬂ  ammatory cells in the vessel wall, 
SMCs induced by low TNF-α will provide stability to the ves-
sel preventing rupture (stabilized aneurysms). Alternatively, 
sTNFRs could also reduce TNF-α activity on vascular cells 
and stabilize aneurysms.
Therapeutic potential of TNF-α
Though the mechanical integrity of the arterial wall is 
compromised in the aneurysm wall, the molecular signals 
from immune cells that initiate aneurysm development and 
progression are not known. If TNF-α from immune cells is 
critically important for aneurysm development and growth, 
it ought to breach the protective barrier of the vascular 
endothelium by promoting free ﬂ  ow of inﬂ  ammatory cells 
mediators over and across endothelium. Many studies have 
demonstrated the presence of various adhesion molecules 
and chemokines at sites of inﬂ  ammation particularly in 
atherosclerosis. Given enhanced expression of adhesion 
molecules and chemoattractants in IA, it seems logical to 
conclude that large numbers of inﬁ  ltrating leukocytes are 
recruited into the aneurysm site by these molecules. These 
chemokines may be anchored to the cell surface, thereby 
ensuring a relatively high concentration of chemoattrac-
tants close to the cerebral aneurysm formation site, hence 
temporally and spatially restricting activation of circulating 
cells. It is possible to target and modulate components of 
the adhesion-migration pathway with TNF-α inhibitors. A 
complementary strategy would be to down-regulate TNF-α 
activity in inﬁ  ltrating leukocytes with intracellular calcium 
channel inhibitors. Since several inﬂ  ammatory pathways are 
dependent on Ca2+ (for instance, TNF-α, MMP-9 processing, 
NFκB, and NFAT activation), inhibiting Ca2+ concentration 
may be beneﬁ  cial.
Future perspectives
Use of mouse models to gain insights 
on human aneurysms
Since temporal analysis of the genetic changes in humans 
is not feasible, development of cerebral aneurysms in mice 
would additionally help to clarify the role of TNF-α in aneu-
rysm growth and rupture. To carefully study the development 
and growth of aneurysms in vivo, experimental aneurysms 
at bifurcations of cerebral arteries must 1) recapitulate the 
essential features of human cerebral aneurysms; and 2) be 
amenable to experimental manipulation. Transgenic mice or 
knock out mice can be employed to assess the involvement 
of speciﬁ  c genes in cerebral aneurysms. Further studies on 
TNF-α transgenic and null mice will greatly facilitate its 
role in the patho-physiology of cerebral aneurysms because 
1) aneurysm formation and growth can be directly related to 
the presence and absence of TNF-α expression, respectively; Vascular Health and Risk Management 2008:4(4) 815
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2) it would provide better insights on continuous arterial 
remodeling, as seen in human aneurysms; 3) TNF-α spe-
ciﬁ  c antibodies and antagonists as well as soluble TNFR1 
and TNFR2 (sTNFR1 and sTNFR2) are easily available to 
experimentally manipulate and neutralize the TNF-α effects 
in vivo. Experimental aneurysms in TNF-α transgenic and 
deﬁ  cient mice, especially hemodynamically-induced intra-
cranial aneurysms, will be invaluable for establishing a casual 
relationship among hemodynamic stresses to TNF-α activity 
changes in inﬂ  ammation and aneurysm growth. Determin-
ing whether TNF-α is involved in the etiology of cerebral 
aneurysms and hemorrhage may lead to the development of 
rational therapeutic interventions.
While higher TNF-α expression in aneurysms offers 
some clues, there are several key questions that remain unan-
swered: Why do only a few aneurysms rupture? Can TNF-α 
be involved in both progression and rupture? Is persistent 
activation a cause of aneurysm rupture? And, is it possible 
to prevent aneurysm progression and rupture by blocking 
TNF-α activity? The answers to these questions will lead to 
a better understanding of aneurysm disease.
Development of small molecule antagonists
Management of un-ruptured IA is a major health problem 
due to lack of predictability in terms of growth and rupture 
(Berenstein et al 1999). As we understand the complexities 
of inﬂ  ammation in aneurysm walls, we are presented with 
several challenges in the quest to develop potent, speciﬁ  c 
anti-inﬂ  ammatory agents that do not limit host defense. 
First, how do we integrate all the information on inﬂ  am-
matory cytokines into our understanding of inﬂ  ammatory 
processes? This is required for value to be assigned to the 
importance of various targets. Second, how useful will it 
to be to target a major signaling pathway, such as TNF-α, 
which has physiological as well as pathological roles in 
inﬂ  ammation? This is a key concern, given the potential 
problem with targeting TNF-α. Inhibitors of this pathway 
could be useful in the acute context, as in sepsis. However, 
interfering with speciﬁ  c protein–protein interactions pres-
ents attractive possibilities. This receptor interference can be 
receptor-proximal, or at the level of transcriptional control 
as speciﬁ  cities of interactions are apparent in the context 
of aneurysm growth. For instance, differential effects of 
TNF-α-mediated inﬂ  ammation and apoptosis can be studied 
by limiting apoptosis and inﬂ  ammation through antagonists 
to FADD and NFκB, respectively.
Finally, developing inhibitors of protein–protein interac-
tions may present a considerable challenge. Even if speciﬁ  c 
peptide inhibitors with internalization sequences are devel-
oped, it seems unlikely that this will form the basis for new 
drugs. We may have to use the peptides as lead compounds 
from which to develop peptido-mimetics and/or other com-
pounds. This exciting prospect may prove challenging but 
the rewards can be tremendous. New treatments to prevent 
aneurysm growth can be increased by targeting TNF-α-medi-
ated inﬂ  ammation in these patients.
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